Clinical trial
Acute Respiratory Illness Surveillance (ARIS) by Monitoring Voice and Illness Symptom Changes Using a Mobile Application in a Low-Interventional Decentralized Study.
NCT04748445 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Respiratory Illness Surveillance (ARIS) by Monitoring Voice and Illness Symptom Changes Using a Mobile Application in a Low-Interventional Decentralized Study.
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 12, 2021
- Completion date
- April 22, 2022
- Enrollment
- 9,151 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy